Where does Rik Kielman work?

Rik Kielman is Chief Executive Officer (CEO) at Implican.

Where did Rik Kielman go to school?

Rik Kielman studied at Hanze (BA, Business Management); CELforPharma (Health Economics for Non-Health-Economics, Cost-effectiveness studies, assess quality of studies from payer's perspective).

Rik Kielman

Chief Executive Officer (CEO) at Implican

Greater Groningen Area

Find your path to Rik

41 people in our graph share verified history with Rik — schools, employers, funds. One of them is your warm intro.

Marnix van der PloegunlockedRik: together at Hanze (1994–1995)

×10Rik: together at Hanze

Rik: together at CELforPharma

Chief Executive Officer (CEO) at Implican

Intro paths

→

In turn, Rik can intro founders to Implican's investors below.

Implican's investors · 2

Nom NV NOMGroningen

Experience

IMPLICAN B.V.Chief Executive Officercurrent2026 — presentGreater Groningen Area
SensiusCCO at Sensius2022 — 2026Rotterdam, South Holland, Netherlands
SensiusDirector Marketing & Sales2020 — 2022Rotterdam, South Holland, Netherlands
Gannet B.V.Hospital introduction manager2013 — 2022Groningen
Berrnell Food BVManaging Director2005 — 2013Groningen
InnosourceBusiness Development Director2010 — 2013Groningen
Freia/EDIAssistant business development2002 — 2005
Sapa AluminiumAccount manager2000 — 2002

Skills & more

Hospital ReimbursementClinical TrialsNew Product RolloutFundraisingBusiness-to-Business (B2B)Key Account Management1Business Strategy4B2B1Business Development6Sales Management1International Sales1Marketing Strategy3

+7 more

New Business DevelopmentProduct DevelopmentFinanceEntrepreneurshipManagementStart-upsSales

From Rik's professional profile.

Frequently asked questions

Who is Rik Kielman?: Chief Executive Officer (CEO) at Implican
Where does Rik Kielman work?: Rik Kielman is Chief Executive Officer (CEO) at Implican.
Where did Rik Kielman go to school?: Rik Kielman studied at Hanze (BA, Business Management); CELforPharma (Health Economics for Non-Health-Economics, Cost-effectiveness studies, assess quality of studies from payer's perspective).

Same school

Also attended Hanze35

Jelle Van de PutteFund Administrator at Capricorn Venture Partners Marnix van der PloegInvestor at EQT Ventures Matt HovingDirector of Business Development at Griffin Gaming Partners Anton KellerInvestor at Newion Alexander HuberCFO at UVC Partners Kareem DabbaghManaging Partner at VoLo Earth Ventures

+ 29 more

Also attended CELforPharma4

Steven BiesmansPrincipal at UCB Ventures Akeem GardnerFounder at Canurta Therapeutics Website Timothy PereraFounder & CEO at Deuteroncology Peter SchiemannFounder at iQure Pharma

Shared employers

Also worked at IMPLICAN B.V.2

Meike BomhofInvestor at NextGen Ventures Ivo KooijmanChief Technology Officer (CTO) at Implican

Also worked at Innosource1

Mark KvammePartner at Drive Capital